Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets.

PubWeight™: 1.57‹?› | Rank: Top 4%

🔗 View Article (PMC 4048923)

Published in Nat Rev Gastroenterol Hepatol on June 25, 2013

Authors

Gary M Mawe1, Jill M Hoffman

Author Affiliations

1: Department of Neurological Sciences, D403A Given Building, 89 Beaumont Avenue, University of Vermont, Burlington, VT 05405, USA. gary.mawe@uvm.edu

Associated clinical trials:

Cognitive and Biological Responses in Stress | NCT05026333

Articles citing this

Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell (2015) 3.67

Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J (2014) 1.20

A xenogeneic-free system generating functional human gut organoids from pluripotent stem cells. JCI Insight (2017) 1.07

Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci (2015) 1.06

Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World J Gastroenterol (2014) 1.06

Colonic migrating motor complexes, high amplitude propagating contractions, neural reflexes and the importance of neuronal and mucosal serotonin. J Neurogastroenterol Motil (2014) 1.00

Towards a systems view of IBS. Nat Rev Gastroenterol Hepatol (2015) 0.97

Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms. J Physiol (2014) 0.96

Mechanosensitive ion channel Piezo2 is important for enterochromaffin cell response to mechanical forces. J Physiol (2016) 0.92

Generating human intestinal tissues from pluripotent stem cells to study development and disease. EMBO J (2015) 0.88

The 5-hydroxytryptamine 4 Receptor Agonist-induced Actions and Enteric Neurogenesis in the Gut. J Neurogastroenterol Motil (2013) 0.87

Colitis-induced neuroplasticity disrupts motility in the inflamed and post-inflamed colon. J Clin Invest (2015) 0.86

Ion channelopathies in functional GI disorders. Am J Physiol Gastrointest Liver Physiol (2016) 0.84

Effect of Serotonin Transporter 5-HTTLPR Polymorphism on Gastrointestinal Intolerance to Metformin: A GoDARTS Study. Diabetes Care (2016) 0.83

Serotonin and colonic motility. Neurogastroenterol Motil (2015) 0.83

Role of central vagal 5-HT3 receptors in gastrointestinal physiology and pathophysiology. Front Neurosci (2015) 0.82

From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Mol Psychiatry (2016) 0.82

Prucalopride exerts neuroprotection in human enteric neurons. Am J Physiol Gastrointest Liver Physiol (2016) 0.82

5-HT7 receptor signaling: improved therapeutic strategy in gut disorders. Front Behav Neurosci (2014) 0.81

Enteroendocrine cells: a review of their role in brain-gut communication. Neurogastroenterol Motil (2015) 0.80

Measuring the nausea-to-emesis continuum in non-human animals: refocusing on gastrointestinal vagal signaling. Exp Brain Res (2014) 0.80

Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice. ISME J (2015) 0.80

Prediction and validation of enzyme and transporter off-targets for metformin. J Pharmacokinet Pharmacodyn (2015) 0.80

The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease. Mol Neurobiol (2016) 0.80

IBS and IBD - separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol (2016) 0.79

A sexually dimorphic effect of cholera toxin: rapid changes in colonic motility mediated via a 5-HT3 receptor-dependent pathway in female C57Bl/6 mice. J Physiol (2016) 0.78

Serotonin-secreting enteroendocrine cells respond via diverse mechanisms to acute and chronic changes in glucose availability. Nutr Metab (Lond) (2015) 0.78

Metabolic alterations in children with environmental enteric dysfunction. Sci Rep (2016) 0.78

Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea. Clin Gastroenterol Hepatol (2014) 0.78

Activation of the umami taste receptor (T1R1/T1R3) initiates the peristaltic reflex and pellet propulsion in the distal colon. Am J Physiol Gastrointest Liver Physiol (2014) 0.78

Delivery of enteric neural progenitors with 5-HT4 agonist-loaded nanoparticles and thermosensitive hydrogel enhances cell proliferation and differentiation following transplantation in vivo. Biomaterials (2016) 0.78

Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters. Pharmacol Rev (2016) 0.78

Electrochemical fecal pellet sensor for simultaneous real-time ex vivo detection of colonic serotonin signalling and motility. Sci Rep (2016) 0.78

Mechanosensory Signaling in Enterochromaffin Cells and 5-HT Release: Potential Implications for Gut Inflammation. Front Neurosci (2016) 0.78

Novel therapeutic agents in neurogastroenterology: advances in the past year. Neurogastroenterol Motil (2014) 0.77

Serotonin-Exacerbated DSS-Induced Colitis Is Associated with Increase in MMP-3 and MMP-9 Expression in the Mouse Colon. Mediators Inflamm (2016) 0.77

Chemical and molecular factors in irritable bowel syndrome: current knowledge, challenges, and unanswered questions. Am J Physiol Gastrointest Liver Physiol (2016) 0.77

Protective Actions of Epithelial 5-Hydroxytryptamine 4 Receptors in Normal and Inflamed Colon. Gastroenterology (2016) 0.76

Sertraline use in the first trimester and risk of congenital anomalies: a systemic review and meta-analysis of cohort studies. Br J Clin Pharmacol (2016) 0.76

Human Derived Gut Microbiota Modulates Colonic Secretion in Mice by Regulating 5-HT3 Receptor Expression via Acetate Production. Am J Physiol Gastrointest Liver Physiol (2017) 0.75

Correlated gene expression encoding serotonin (5-HT) receptor 4 and 5-HT transporter in proximal colonic segments of mice across different colonization states and sexes. Neurogastroenterol Motil (2016) 0.75

The TNF-α antagonist etanercept reverses age-related decreases in colonic SERT expression and faecal output in mice. Sci Rep (2017) 0.75

Salmonella Typhimurium and Multidirectional Communication in the Gut. Front Microbiol (2016) 0.75

Effect of daytime-restricted feeding in the daily variations of liver metabolism and blood transport of serotonin in rat. Physiol Rep (2015) 0.75

Global hypoxia-ischemia induced inflammation and structural changes in the preterm ovine gut which were not ameliorated by mesenchymal stem cell treatment. Mol Med (2016) 0.75

Non-conventional features of peripheral serotonin signalling - the gut and beyond. Nat Rev Gastroenterol Hepatol (2017) 0.75

Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea. Gastroenterology (2016) 0.75

Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome. Microbiome (2017) 0.75

The Role of H. pylori CagA in Regulating Hormones of Functional Dyspepsia Patients. Gastroenterol Res Pract (2016) 0.75

Role of serotonin on the intestinal mucosal immune response to stress-induced diarrhea in weaning mice. BMC Gastroenterol (2017) 0.75

Genetic and biochemical changes of the serotonergic system in migraine pathobiology. J Headache Pain (2017) 0.75

Bugs, genes, fatty acids, and serotonin: Unraveling inflammatory bowel disease? F1000Res (2015) 0.75

Neurobiological Mechanism of Acupuncture for Relieving Visceral Pain of Gastrointestinal Origin. Gastroenterol Res Pract (2017) 0.75

Altered tryptophan hydroxylase 2 expression in enteric serotonergic nerves in Hirschsprung's-associated enterocolitis. World J Gastroenterol (2016) 0.75

Reduction of epithelial secretion in male rat distal colonic mucosa by bile acid receptor TGR5 agonist, INT-777: role of submucosal neurons. Neurogastroenterol Motil (2016) 0.75

RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives. Bioessays (2016) 0.75

Effects of Single-Dose Prucalopride on Intestinal Hypomotility in Horses: Preliminary Observations. Sci Rep (2017) 0.75

Common Functional Gastroenterological Disorders Associated With Abdominal Pain. Mayo Clin Proc (2016) 0.75

Intestinal Serotonin Transporter Inhibition by Toll-Like Receptor 2 Activation. A Feedback Modulation. PLoS One (2016) 0.75

Piezos thrive under pressure: mechanically activated ion channels in health and disease. Nat Rev Mol Cell Biol (2017) 0.75

Targeting the gut to treat obesity and its metabolic consequences: view from the Chair. Int J Obes Suppl (2016) 0.75

Biscuits with No Added Sugar Containing Stevia, Coffee Fibre and Fructooligosaccharides Modifies α-Glucosidase Activity and the Release of GLP-1 from HuTu-80 Cells and Serotonin from Caco-2 Cells after In Vitro Digestion. Nutrients (2017) 0.75

Serotonergic Mechanisms Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance. Handb Exp Pharmacol (2016) 0.75

Sugars, Sweet Taste Receptors, and Brain Responses. Nutrients (2017) 0.75

Close association between intestinal microbiota and irritable bowel syndrome. Eur J Clin Microbiol Infect Dis (2017) 0.75

Role of SHP2 protein tyrosine phosphatase in SERT inhibition by enteropathogenic E. coli (EPEC). Am J Physiol Gastrointest Liver Physiol (2017) 0.75

Using Animal Models to Study the Role of the Gut-Brain Axis in Autism. Curr Dev Disord Rep (2017) 0.75

Cross Talk: The Microbiota and Neurodevelopmental Disorders. Front Neurosci (2017) 0.75

UTP - Gated Signaling Pathways of 5-HT Release from BON Cells as a Model of Human Enterochromaffin Cells. Front Pharmacol (2017) 0.75

A role for the serotonin reuptake transporter in the brain and intestinal features of autism spectrum disorders and developmental antidepressant exposure. J Chem Neuroanat (2017) 0.75

Mechanosensitive Piezo Channels in the Gastrointestinal Tract. Curr Top Membr (2017) 0.75

Articles cited by this

(truncated to the top 100)

Functional bowel disorders. Gastroenterology (2006) 20.72

The effect of intraluminal application of 5-hydroxytryptamine and 5-hydroxytryptophan on peristalsis; the local production of 5-HT and its release in relation to intraluminal pressure and propulsive activity. J Physiol (1958) 7.76

Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08

Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell (2008) 5.93

The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology (2007) 4.58

Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav (2002) 4.54

Vagal sensory receptors and their reflex effects. Physiol Rev (1973) 4.51

Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology (2004) 4.04

The expanded biology of serotonin. Annu Rev Med (2009) 3.87

Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br J Pharmacol (1986) 2.93

Cloning and expression of a functional serotonin transporter from rat brain. Nature (1991) 2.86

A transient placental source of serotonin for the fetal forebrain. Nature (2011) 2.71

Observations concerning the action of 5-hydroxytryptamine on the peristaltic reflex. Br J Pharmacol Chemother (1958) 2.55

Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology (2009) 2.55

Serotonin regulates mammary gland development via an autocrine-paracrine loop. Dev Cell (2004) 2.40

Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat Med (2010) 2.32

A unique central tryptophan hydroxylase isoform. Biochem Pharmacol (2003) 2.23

Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons. J Neurosci (2011) 2.21

5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J Neurosci (2009) 2.21

Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc Natl Acad Sci U S A (2003) 2.19

Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters. J Neurosci (2001) 2.19

The release of 5-hydroxytryptamine in relation to pressure exerted on the intestinal mucosa. J Physiol (1959) 2.17

Activation of colonic mucosal 5-HT(4) receptors accelerates propulsive motility and inhibits visceral hypersensitivity. Gastroenterology (2012) 2.11

Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor. J Pharmacol Exp Ther (1990) 1.97

Localized release of serotonin (5-hydroxytryptamine) by a fecal pellet regulates migrating motor complexes in murine colon. Gastroenterology (2008) 1.97

Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol (2005) 1.93

Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology (2006) 1.91

Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol Interv (2004) 1.89

The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome. Gastroenterology (2011) 1.88

Identification and stimulation by serotonin of intrinsic sensory neurons of the submucosal plexus of the guinea pig gut: activity-induced expression of Fos immunoreactivity. J Neurosci (1992) 1.86

Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology (2006) 1.85

Decreased osteoclastogenesis in serotonin-deficient mice. Proc Natl Acad Sci U S A (2012) 1.84

Release of 5-hydroxytryptamine from the mucosa is not required for the generation or propagation of colonic migrating motor complexes. Gastroenterology (2009) 1.81

The action of 5-hydroxytryptamine, 5-hydroxytryptophan and reserpine on intestinal peristalsis in anaesthetized guinea-pigs. J Physiol (1959) 1.79

Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther (2012) 1.79

Neurochemical classification of myenteric neurons in the guinea-pig ileum. Neuroscience (1996) 1.78

5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology (1998) 1.78

Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol (2003) 1.78

5-Hydroxytryptamine M-receptor antagonism to prevent cisplatin-induced emesis. Neuropharmacology (1986) 1.78

Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat. J Physiol (2001) 1.78

Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve. Br J Pharmacol (1987) 1.77

Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci (1996) 1.76

Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2012) 1.73

Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract. J Pharmacol Exp Ther (2008) 1.73

Sensory transmission in the gastrointestinal tract. Neurogastroenterol Motil (2007) 1.71

Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation. Gastroenterology (2011) 1.70

Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum. Neurogastroenterol Motil (2002) 1.70

Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs (1988) 1.66

Real-time detection of serotonin release from enterochromaffin cells of the guinea-pig ileum. Neurogastroenterol Motil (2004) 1.62

Review article: intestinal serotonin signalling in irritable bowel syndrome. Aliment Pharmacol Ther (2006) 1.61

5-HT4 receptor agonists: similar but not the same. Neurogastroenterol Motil (2008) 1.59

Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut (2003) 1.54

Neurons with 5-hydroxytryptamine-like immunoreactivity in the enteric nervous system: their projections in the guinea-pig small intestine. Neuroscience (1982) 1.52

Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol (2008) 1.52

Production of serotonin by tryptophan hydroxylase 1 and release via platelets contribute to allergic airway inflammation. Am J Respir Crit Care Med (2013) 1.49

Propulsion in guinea pig colon induced by 5-hydroxytryptamine (HT) via 5-HT4 and 5-HT3 receptors. J Pharmacol Exp Ther (1999) 1.47

5-HT2B receptors do not modulate sensitivity to colonic distension in rats with acute colorectal hypersensitivity. Neurogastroenterol Motil (2006) 1.46

Prolonged stationary colonic motility recording in seven patients with severe constipation secondary to antidepressants. Neurogastroenterol Motil (2000) 1.45

Activation of intrinsic afferent pathways in submucosal ganglia of the guinea pig small intestine. J Neurosci (2000) 1.42

Impulses in vagal afferent fibres from stretch receptors in the stomach and their role in the peripheral mechanism of hunger. Nature (1953) 1.42

The terminals of myenteric intrinsic primary afferent neurons of the guinea-pig ileum are excited by 5-hydroxytryptamine acting at 5-hydroxytryptamine-3 receptors. Neuroscience (2000) 1.39

Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome. Aliment Pharmacol Ther (2007) 1.39

Peripheral neural serotonin receptors: identification and characterization with specific antagonists and agonists. Proc Natl Acad Sci U S A (1986) 1.39

In vitro continuous amperometric monitoring of 5-hydroxytryptamine release from enterochromaffin cells of the guinea pig ileum. Analyst (2006) 1.37

Observations on the release and turnover rate of 5-hydroxytryptamine in the gastrointestinal tract. J Pharm Pharmacol (1959) 1.37

Colonic endocrine cells in inflammatory bowel disease. J Intern Med (1997) 1.35

Human mast cells are capable of serotonin synthesis and release. J Allergy Clin Immunol (2006) 1.34

Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment Pharmacol Ther (1992) 1.32

Multiple mechanisms of fast excitatory synaptic transmission in the enteric nervous system. J Auton Nerv Syst (2000) 1.32

Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice. Am J Physiol Gastrointest Liver Physiol (2008) 1.31

Tissue-specific mathematical models of slow wave entrainment in wild-type and 5-HT(2B) knockout mice with altered interstitial cells of Cajal networks. Biophys J (2010) 1.31

A method of locating the receptors of visceral afferent fibres. J Physiol (1954) 1.29

Participation of 5-HT3, 5-HT4, and nicotinic receptors in the peristaltic reflex of guinea pig distal colon. Am J Physiol (1996) 1.29

Neuronal serotonin regulates growth of the intestinal mucosa in mice. Gastroenterology (2012) 1.29

Tissue 5-hydroxytryptamine and urinary 5-hydroxyindoleacetic acid after partial or total removal of the gastro-intestinal tract in the rat. J Physiol (1960) 1.28

Neurotransmitters in neuronal reflexes regulating intestinal secretion. Ann N Y Acad Sci (2000) 1.28

Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients. Gastroenterology (2010) 1.27

Lack of serotonin 5-HT2B receptor alters proliferation and network volume of interstitial cells of Cajal in vivo. Neurogastroenterol Motil (2009) 1.26

Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying. Am J Physiol Gastrointest Liver Physiol (2002) 1.26

Life without peripheral serotonin: insights from tryptophan hydroxylase 1 knockout mice reveal the existence of paracrine/autocrine serotonergic networks. ACS Chem Neurosci (2012) 1.23

Exogenous serotonin regulates proliferation of interstitial cells of Cajal in mouse jejunum through 5-HT2B receptors. Gastroenterology (2007) 1.23

Serotonin and cholecystokinin activate different populations of rat mesenteric vagal afferents. Neurosci Lett (1998) 1.23

Guinea pig 5-HT transporter: cloning, expression, distribution, and function in intestinal sensory reception. Am J Physiol (1998) 1.23

Mast cell-nerve axis with a focus on the human gut. Biochim Biophys Acta (2011) 1.22

Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine. Gastroenterology (1996) 1.22

GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci (1990) 1.20

The functional impact of SLC6 transporter genetic variation. Annu Rev Pharmacol Toxicol (2007) 1.20

Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis. Neurogastroenterol Motil (2005) 1.17

Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Am J Physiol Gastrointest Liver Physiol (2003) 1.17

High mucosal serotonin availability in neonatal guinea pig ileum is associated with low serotonin transporter expression. Gastroenterology (2007) 1.17

Mechanisms underlying distension-evoked peristalsis in guinea pig distal colon: is there a role for enterochromaffin cells? Am J Physiol Gastrointest Liver Physiol (2011) 1.16

Effects of serotonin transporter inhibition on gastrointestinal motility and colonic sensitivity in the mouse. Neurogastroenterol Motil (2006) 1.14

Expression and function of 5-HT4 receptors in the mouse enteric nervous system. Am J Physiol Gastrointest Liver Physiol (2005) 1.14

Relationship of SERT polymorphisms to depressive and anxiety symptoms in irritable bowel syndrome. Biol Res Nurs (2007) 1.14

Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials. Clin Ther (2008) 1.13

5-HT1A and 5-HT4 receptors mediate inhibition and facilitation of fast synaptic transmission in enteric neurons. Am J Physiol (1994) 1.13

Expression of 5-HT3 receptors in the rat gastrointestinal tract. Gastroenterology (2002) 1.12

Serotonin and the 5-HT(2B) receptor in the development of enteric neurons. J Neurosci (2000) 1.11

Sensitivity to 5-hydroxytryptamine in different afferent subpopulations within mesenteric nerves supplying the rat jejunum. J Physiol (1998) 1.10

Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil (2005) 1.10